Coronary Stents Market Trends, Procedure Volume, Healthcare Spending, Technology Adoption, Reimbursement Analysis, Cost Structure, Market Penetration, and Growth Outlook

Revenue, 2025

USD 10.35 billion

Forecast Year, 2035

USD 18.3 billion

CAGR, 2026 - 2035

5.86%

Report Coverage

Global

What is the Coronary Stents Market Size?

The global coronary stents market size is calculated at USD 10.35 billion in 2025 and is predicted to increase from USD 10.97 billion in 2026 to approximately USD 18.3 billion by 2035, expanding at a CAGR of 5.86% from 2026 to 2035. The coronary stents market is driven by the rising prevalence of cardiovascular diseases, increasing minimally invasive procedures, technological advancements in drug-eluting stents, and aging populations.

Coronary Stents Market Key Takeaways

• In terms of revenue, the market is valued at $10.35 billion in 2025.
• It is projected to reach $18.3 billion by 2035.
• The market is expected to grow at a CAGR of 5.86% from 2026 to 2035.
• North America led the global market with the highest market share of 33% in 2025.
• The Drug-Eluting Stents (DES) segment had the largest market share of 66.4% in 2025.
• The metallic biomaterial segment accounted largest market share in 2025.

Market Overview

Increasing geriatric population across the globe Andy different types of diseases associated with the aging population shall be the factors that shall be increasing the demand for the coronary stents. The geriatric population suffers with cardiovascular diseases, obesity, diabetes and complex lesions and all of these shall create a demand for the coronary stents in the coming years. The increased cases of coronary heart disease have been one of the major causes for the deaths across the world. About 17.9 million people suffering from cardiovascular diseases succumbed to death in the recent years and the number will continue to grow during the forecast period. The increasing cases of coronary heart disease is and fatalities caused due to the disease shall be a driving factor for the growth of the market in the coming years. Increased awareness regarding the availability of these treatments and success rate is expected to drive the market growth in the coming years. There is a growing demand for the coronary stent devices in the market. These stents are used in most of the procedures of the heart and there was a greater demand created for the coronary stents during the outbreak of the COVID-19 pandemic.

As different types of advancements in the technology have made the market lucrative the demand is expected to grow well during the forecast period. Constant research and development have been instrumental in launching the stents that are fully dissolving. These stents are used in most of the heart surgeries and these stents were launched in the market in the recent years which had secured the approval from the FDA. The increasing cases of coronary artery diseases shall create a greater demand for these treatments. The availability of the bioengineered stents and the stents of dual therapy shall we instrumental in the growth of the demand for this treatment. Other factors that are expected to play an important role in the growth of the market are the coatings used, the material as well as the construction which is used in the technology.

Most of the market players have gained I'm pretty advantage over the years due to constant research and development as new innovative products are launched in the market. Angioplasties and the bypass surgeries make use of these coronary stents. Although the demand for this technology is growing there are a few side effects that are associated with the treatment do to which the market growth shall be hindered in the coming years. The existence of the stringent policies adopted by the government and the various regulations that offered to market will be another factor that shall hinder the growth the market in the coming years.

During the outbreak of the pandemic the disrupted supply chains and shortage of raw material had negative impact on the growth of the market. The demand for the coronary stents had dropped during the initial time of the COVID-19 outbreak. But the overall impact was negligible as eventually the procedures that were delayed were lined up and the market grew.

Coronary Stents Market Growth Factors

Increasing cases of the coronary artery disease is and good results provided by the use of coronary stents in the treatment of the patients shall create a greater demand for the market during the forecast period. Constant research and development activities have provided innovative products in the recent years and the market is expected to grow well during the forecast period. Constant awareness drive about the benefits of the usage of the coronary stent's technology shall drive the market growth even in the developing countries across the globe. The existence of favorable insurance policies or reimbursement policies we will be supportive for the growth of the market in the coming years. Many opportunities for the growth of the market shall be provided in the developing nations of the world.

About 90% of the percutaneous coronary intervention procedures make use of the coronary stents. other invasive surgeries of the heart also make use of these stents on a large scale. The use of the coronary stents does not cause any big incisions and they are considered to be minimally invasive. The demand of these procedures will continue to grow even during the forecast period during the various benefits provided by the technology. It reduces the amount of the surgical trauma, the pain felt by the patient is lesser as compared to the other alternatives, reduced scarring, as the procedure is minimally invasive the stay at the hospital is also reduced. Increasing geriatric population across the globe and the various heart conditions associated with the aging population shall be a major reason for the growth of the market during the forecast period.

As the constant research and development activities have provided the stents that are fully dissolving the market shall see growth in the coming year. The launch of the bioengineered stents shall also be instrumental for the growth of the market. The coatings the construction and the material used in this technology will play a major role in the growth. Most of the market players are focusing on various development strategies through partnerships. The sedentary lifestyle of the people and increasing habits of eating while watching TV shall be another reason for the growing demand for this technology. Increased level of stress due to the sedentary lifestyles will increase the number of cardiovascular diseases in the coming years. The growing demand for the minimally invasive surgeries in the developed as well as the developing economies and the increased purchasing power shall lead to the growth of the market of the coronary stents during the forecast period.

Coronary Stents Market Outlook

• Overview of Industry Growth: The market for coronary stents is growing because of the increased cases with coronary artery disease, the popularity of minimally invasive procedures, the ongoing development of both biodegradable and drug-eluting stents, and finally, access to advanced cardiac care in both developed and developing health systems.
• Global Expansion: Manufacturers are expending their market presence through obtaining regulatory approvals, localizing production, developing partnerships with hospitals, and increasing their distribution networks. High investments in healthcare sector and infrastructural developments of catheterization laboratories in Asia-Pacific region, Latin America, and the Middle East are the factors supporting increase of use of coronary stents.
• Sustainability Trends: Manufacturers are embracing sustainability in production by minimizing the amount of wasted materials, electric energy and using less packaging. The focus on environmentally friendly medical devices production corresponds with new healthcare procurement policies and organizations' commitment towards sustainability.
• Startup Ecosystem: The new generation coronary stents produced by startups based on modern biomaterials, biodegradable technologies, innovative coating, artificial intelligence-assisted planning, and new methods of product delivery. Collaborations with scientific institutions and companies producing medical equipment lead to commercialization and innovations in interventional cardiology.

Market Scope

Market Dynamics

Driver

Increasing Rate of Cardiovascular Disease

The increase in coronary artery disease, heart attack, diabetes, obesity, and older population results in more people needing coronary intervention. Increasing awareness of the significance of diagnosis, easier access to cardiac care, and broader implementation of minimally invasive techniques boost the demand for sophisticated coronary stents aimed at improving blood supply, decreasing complications, and improving long-term patient results.

Restraints

Cost of Procedures

The high cost of the coronary stenting procedure, which covers hospital stay, images, medical doctor fees, and aftercare, reduces the access to the procedure in low and middle-income countries. Although reimbursement improved in some countries, issues of affordability still prevent the spread of modern and future stenting methods in these countries.

Opportunities

New Development in Stent Technologies

Ongoing innovative breakthroughs in bioabsorbable scaffolds and polymer-free drug-eluting stents, as well as AI-based planning of the procedure processes, provide the horizons for advancement. Innovations in stent technologies are made to facilitate vascular healing, diminish the possibility of restenosis, and thus improve clinical outcomes and attract attention from the medical community.

Segments Insights

Product Insights

On the basis of the product, the drug eluting stents segment will drive the market growth in the coming years period this segment is expected to have a dominant position during the forecast period. The availability of novel drugs in this segment lead to an increased distribution of the product.

Apart from this segment the bioresorbable stent is also expected to grow well during the forecast period. Increased cases of the cardiovascular diseases shall create a demand for these stains. Increased cases of aging population across the globe shall boost the market.

The Drug-Eluting Stents (DES) segment accounted for the dominating share of 66.40% in 2024. The growth of the segment is majorly driven by the superior performance of drug-eluting stents (DES) in preventing restenosis. Drug-Eluting Stents (DES) are highly effective at preventing restenosis, in which condition where the treated artery narrows again. DES is long-term use and is often more cost-effective, owing to the reduced need for follow-up surgeries and hospital stays.

Deployment Insights

On the basis of deployment, the self-expandable stent segment will grow well during the coming years. Over the years it has been noted that the efficiency of this type of deployment has been extremely good due to which the market is expected to grow well in the coming years period there's a growing demand for this type of deployment across many countries of the globe. As these stents provide better efficiency in the performance of the procedures and enhanced results after the procedures the market growth for this segment is expected to be good during the forecast period.

The balloon expandable segment will also see a steady growth in the coming years due to the increasing geriatric population and increased cases of heart diseases.

End User Insights

On the basis of the end user, the hospital segment has had a largest market share in 2025 and it is expected to grow well in the coming years period most of the surgeries like the angioplasty are performed in the hospital infrastructure. Due to the availability of the best facilities at the hospital shall be instrumental for the growing demand of these procedures in the hospitals.

Biomaterials Insights

The metallic biomaterials segment held a dominant presence in the coronary stents market in 2025, with 64.00%. Metallic biomaterials are gaining immense popularity, owing to their durability, strength, biocompatibility, and radiopacity. They are highly compatible with the human body, reducing adverse reactions which facilitates successful integration.

End-User Insights

The hospitals segment held the major market share of 58.00% in 2025. The hospitals are the significant end users, with larger medical centers leading the increased adoption of advanced stent technologies. Hospitals are central end users to the rising adoption of minimally invasive techniques, which account for the stent procedures. Hospitals offers specialized cardiology departments and equipment for complex procedures which makes them the preferrable setting for stent placement.

Type of Expansion Insights

The balloon-expandable stents segment registered its dominance with 68.00% over the global coronary stents market in 2025. The growth of the segment is attributed to the rising prevalence of cardiovascular diseases, expanding healthcare infrastructure in emerging markets, and an aging global population. Balloon-expandable stents are widely used for treating narrowed coronary arteries, and their growth is also fuelled by the ongoing advancements in technology.

Application Insights

The coronary artery disease segment contributed the biggest market share of 91.00% in 2025. The growth of the segment is supported to the increasing prevalence of coronary artery disease (CAD), surge in aging population and rise in lifestyle changes. Moreover, the increasing preference for minimally invasive procedures like angioplasty with stent placement, propelling the growth of the segment during the forecast period. The rapid innovations such as drug-eluting stents (DES), which release medication to prevent artery re-narrowing, and bioresorbable stents, improves treatment outcomes.

Regional Insights

U.S. Coronary Stents Market Size and Growth 2026 to 2035

The U.S. coronary stents market size is estimated at USD 2.40 billion in 2025 and is predicted to be worth around USD 4.33 billion by 2035, at a CAGR of 6.08% from 2026 to 2035.

The market for the coronary stents is expected to grow well in the North American region. The North America region has had a share of about 33.14% in the past in terms of revenue and it is expected to grow well in the coming years. As the maximum population in the North American region leads an extremely sedentary lifestyle there has been an increase in the cases of obesity and the other cardiovascular diseases. Increased number of ischemic heart diseases, heart attack as well as stroke shall create demand for the coronary stents in the coming years for the North American region. Presence of the various market players in the North American region which constantly focus on the research and development activities and have played an instrumental role in providing better advancements in the technology will drive the market grew during the forecast period. The innovative products offer to the market like the entirely dissolving Stents and the use of the biodegradable materials for the making of these stents shall drive the market growth in the coming years.

U.S. Market Trends

Currently, the U.S. is the leading market in the region due to its large number of cardiac patients, well-developed catheterization laboratory network, effective clinical research ecosystem, and quick adoption of next-generation coronary stent technologies, which are favorably influenced by sound healthcare investment. Regular investments in cardiology field, increasing use of AI-based diagnostic tools and high volume of PCI contribute to the USA's superiority in the coronary stenting market.

Asia Pacific Coronary Stents Market Trends

The Asia Pacific region will also have a good demand for the coronary stents in the coming years. This technology will generate a good revenue for this region. Increased spending on the health care facilities and the growth of the economy off various nations in the Asia Pacific region will drive the market growth period constant awareness regarding the benefits of such procedures and the recent regulatory policies shall be instrumental in the growth of the market. The presence of the insurance facilities and favorable reimbursement policies in the nations like South Korea and Australia will drive the market growth period government of various nations in the Asia Pacific region having increased the number of investments made for developing the healthcare system. These initiatives focused on providing affordable services to the consumers, and the affordable prices have played a great role in the development of the market for China and India. In order to cut down the prices for these procedures' government is engaged in taking initiatives that enable the supply of the products directly from the manufacturer and this will drive the market growth for China.

China Market Trends

China is one of the main sources of development due to the growing number of hospitals, increasing amount of PCIs, increasing incidence of heart issues, and the government's efforts to make advanced cardiac clinics and local medical goods available. Rising healthcare costs, rapid urbanization, aging population, growing popularity of minimally invasive methods and constant development of tertiary clinics boost the demand for coronary stents in the country.

Europe Coronary Stents Market Trends

Europe is the second-largest region in the coronary stents market, mainly because of its developed healthcare system, increasing aging population, and growing prevalence of cardiovascular disease. Ongoing advancements to technology and strong regulatory support for new cardiac devices also influence overall market growth and procedure adoption rates within Europe.

Germany Market Trends

Germany has the largest share of Europe's coronary stent market because of their leading cardiac care centers, increasing rates of heart diseases, and strong governmental support for healthcare innovation. Germany's systematic approach focused on minimally-invasive treatments, and utilization of next-generation stents develop their leadership within the region.

Middle East & Africa Coronary Stents Market Trends

Due to advancements in healthcare, increased rates of heart ailments, and increased investment in specialized heart treatment facilities, the market for coronary stents in the Middle East & Africa is expected to grow at a good rate. There are other factors promoting the usage of coronary stents, including knowledge of non-invasive medical processes, and the spread of medical tourism.

Saudi Arabia Market Trends

Saudi Arabia is the main market in the region, thanks to the increasing rates of heart diseases, the expanding number of cardiac care centers, and government funding aimed at improvement of the availability of healthcare services.

Latin America Coronary Stents Market Trends

The Latin American market for coronary stents is developing slowly due to the increase in heart disease incidence, better medical services, more interventional cardiology specialists, and more investment in hospitals. An increase in knowledge of the importance of timely treatment for heart ailments helps develop market trends.

Brazil Market Trends

Brazil is the leader in the Latin America market thanks to a large number of consumers, more cardiology clinics and hospitals, and the increasing number of cardiac surgeries.

Coronary Stents Market Companies

• Medtronic plc
• Cook Medical
• B. Braun Melsungen AG
• Terumo Corporation
• Vascular Concepts
• STENTYS SA
• MicroPort Scientific Corporation
• Meril Life Sciences Pvt. Ltd
• Translumina
• Biosensors International Group Limited
• Abbott
• Boston Scientific Corporation
• BIOTRONIK SE & Co. KG

Recent Developments

• In May 2024, Abbott, the global healthcare company, announced the launch of XIENCE Sierra™ Everolimus (drug) Eluting Coronary Stent System in India. XIENCE Sierra is one of the latest generation stents in the XIENCE™ family, now available to people suffering from blocked coronary arteries.
  (Source: https://www.business-standard.com)
• In March 2024, Silk Road Medical, Inc. announced that it has launched its tapered Enroute transcarotid stent system to hospitals in the United States. The launch expands on the company's previous Enroute transcarotid stent system, offering additional configurations to better tailor the transcarotid artery revascularization (TCAR) procedure to patient anatomy.
  (Source: https://evtoday.com)
• A partnership between Chansu Vascular Technologies And cardiovascular systems was announced in the year 2021 and this partnership shall focus on the development of the coronary drug coated balloon and the peripheral drug coated balloon which shall be used in the Stents that are drug eluting.

Segments covered in the Report

By Product Type

• Drug-Eluting Stents (DES)
• Bare-Metal Stents (BMS)
• Bioresorbable Vascular Scaffolds (BVS) / Bioresorbable Stents
• Covered Stents
• Others

By Biomaterials

• Metallic Biomaterials
• Polymeric Biomaterials
• Natural Biomaterials

By End-User

• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Cardiac Centers
• Others (e.g., Catheterization Labs)

By Type of Expansion

• Balloon-Expandable Stents
• Self-Expandable Stents

By Application

• Coronary Artery Disease
• Peripheral Artery Disease

By Geography

• North America
• Latin America
• Europe
• Asia-pacific
• Middle and East Africa